Personal Health Management: Cristiano Ronaldo invests in Bioniq

Bioniq, founded in 2019 in London, is an industry leader in offering advanced artificial intelligence-driven personalised supplementation and health optimisation. Legendary soccer player Cristiano Ronaldo has just become a major shareholder in the company.

Ronaldo has made an investment in Bioniq, bringing its total valuation to $82 million. The athlete has been a Bioniq member since 2022 and regularly takes its personalised supplements. He is also going to participate in future brand and product innovation.

Cristiano Ronaldo invests in Bioniq

The soccer icon’s major investment in Bioniq not only highlights his commitment to optimising health and performance, but continues to signal supplements as a key emerging category for high performance athletes and consumers alike.

“I have experienced the benefits firsthand and can attest to the noticeable difference I have seen in both my performance and recovery,” according to Ronaldo. Bioniq has spent several years analysing users’ blood tests to develop its patented algorithm.

“Cristiano Ronaldo is the perfect partner and shareholder,” said Vadim Fedotov, Co-Founder and CEO of Bioniq. If the personalised supplements are helping the elite athlete, it is clear that the product can help other ambitious consumers reach their goals.

Performance and longevity: Bioniq’s focus

Ronaldo’s investment marks an important moment for Bioniq as the company accelerates global expansion. It has a sizeable focus on the US, Europe and the Middle East. The US is currently contributing more than 60% of total global sales.

Bioniq supplements are pharmaceutical-grade and utilise precise micro-dosing to address each individual’s needs and deficiencies. Each formula is created specifically for an user and features a unique mix of antioxidants, vitamins, minerals, amino acids and others.